
CSL Ltd
ASX:CSL

During the last 3 months CSL Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 10% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/asx/csl/vs/indx/axko">open performance analysis).
The last transaction was made on
Feb 21, 2024
by
Ms Samantha (Sam) Louise Lewis
(Non-executive Director)
, who
bought
32.2k AUD
worth of CSL shares.
During the last 3 months CSL Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 10% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/asx/csl/vs/indx/axko">open performance analysis).
The last transaction was made on
Feb 21, 2024
by
Ms Samantha (Sam) Louise Lewis
(Non-executive Director)
, who
bought
32.2k AUD
worth of CSL shares.
CSL Ltd
Glance View
In the bustling world of biotech innovation, CSL Limited stands as a stalwart, renowned for not just navigating but shaping the industry's intricate landscape. Founded in 1916, this Australian giant has grown from its humble beginnings to become a global leader in the biopharmaceutical sector. CSL operates primarily through two main segments: CSL Behring and Seqirus. CSL Behring is the cornerstone of the company's growth, specializing in the development of life-saving therapies derived from human plasma. These therapies are pivotal in treating rare and serious diseases such as hemophilia, immune deficiencies, and hereditary angioedema. The company has built an impressive collection of facilities across several continents, focusing on plasma collection and processing, which underscores its commitment to advanced therapeutic solutions. Alongside CSL Behring, Seqirus has emerged as a formidable force in the influenza vaccine market and is now one of the world's largest flu vaccine providers. The acquisition and transformation of this division signify CSL’s strategic expansion into broader preventive healthcare. From developing and distributing advanced technologies in cell-based and adjuvanted influenza vaccines to advancing research in universal flu vaccines, Seqirus exemplifies CSL's innovative spirit. Collectively, these divisions illustrate how CSL marries cutting-edge research with robust global operations to generate robust revenues, addressing pressing healthcare needs across the globe while promising new horizons in medical science.

What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.